Related Experiment Video
Updated: Mar 30, 2026

Through the Looking Glass: Time-lapse Microscopy and Longitudinal Tracking of Single Cells to Study Anti-cancer Therapeutics
Published on: May 14, 2016
The homeoprotein DLX3 and tumor suppressor p53 co-regulate cell cycle progression and squamous tumor growth
E Palazzo1, M Kellett1, C Cataisson2
1Laboratory of Skin Biology, NIAMS, NIH, Bethesda, MD, USA.
Abstract:
Epidermal homeostasis depends on the coordinated control of keratinocyte cell cycle. Differentiation and the alteration of this balance can result in neoplastic development. Here we report on a novel DLX3-dependent network that constrains epidermal hyperplasia and squamous tumorigenesis. By integrating genetic and transcriptomic approaches, we demonstrate that DLX3 operates through a p53-regulated network. DLX3 and p53 physically interact on the p21 promoter to enhance p21 expression. Elevating DLX3 in keratinocytes produces a G1-S blockade associated with p53 signature transcriptional profiles. In contrast, DLX3 loss promotes a mitogenic phenotype associated with constitutive activation of ERK. DLX3 expression is lost in human skin cancers and is extinguished during progression of experimentally induced mouse squamous cell carcinoma (SCC). Reinstatement of DLX3 function is sufficient to attenuate the migration of SCC cells, leading to decreased wound closure. Our data establish the DLX3-p53 interplay as a major regulatory axis in epidermal differentiation and suggest that DLX3 is a modulator of skin carcinogenesis.
Insights
The DLX3 protein network controls skin cell division and prevents skin cancer. Loss of DLX3 promotes tumor growth, while its restoration inhibits squamous cell carcinoma cell migration.
Area of Science:
- Dermatology
- Molecular Biology
- Cancer Research
Background:
- Epidermal homeostasis relies on regulated keratinocyte cell cycling.
- Imbalances in cell cycle control can lead to neoplastic development.
- The DLX3 protein's role in skin cancer is not well understood.
Purpose of the Study:
- To investigate the function of a novel DLX3-dependent network in regulating epidermal hyperplasia and squamous tumorigenesis.
- To elucidate the molecular mechanisms by which DLX3 influences the cell cycle and differentiation.
- To determine the role of DLX3 in human skin cancers and squamous cell carcinoma (SCC) progression.
Main Methods:
- Integrated genetic and transcriptomic approaches were used to identify DLX3-regulated pathways.
- Physical interaction between DLX3 and p53 on the p21 promoter was assessed.
- Keratinocyte cell cycle progression was analyzed following DLX3 manipulation.
- ERK pathway activation was measured in DLX3-deficient cells.
- DLX3 expression levels were examined in human skin cancers and experimentally induced mouse SCC.
- The effect of DLX3 reinstatement on SCC cell migration and wound closure was evaluated.
Main Results:
- A novel DLX3-dependent network was identified that constrains epidermal hyperplasia and squamous tumorigenesis.
- DLX3 operates through a p53-regulated network, physically interacting with p53 on the p21 promoter to enhance p21 expression.
- Elevated DLX3 in keratinocytes induced a G1-S cell cycle blockade with p53 transcriptional profiles.
- DLX3 loss promoted a mitogenic phenotype with constitutive ERK activation.
- DLX3 expression was lost in human skin cancers and decreased during SCC progression.
- Restoring DLX3 function attenuated SCC cell migration and reduced wound closure.
Conclusions:
- The DLX3-p53 interplay is a critical regulatory axis in epidermal differentiation and cell cycle control.
- DLX3 acts as a tumor suppressor in the skin, inhibiting keratinocyte proliferation and SCC progression.
- DLX3 loss is associated with skin carcinogenesis, highlighting its potential as a therapeutic target.
Related Concept Videos
Abnormal Proliferation
Negative Regulator Molecules
DNA Damage can Stall the Cell Cycle
DNA Damage Can Stall the Cell Cycle
Inhibition of Cdk Activity
Molecular Factors Affecting Cell Division
Several proteins function as internal regulators to ensure each cell cycle stage is completed faithfully before proceeding to the next. Regulator molecules may act directly or influence the activity or production of other...

